Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Integrating BRAFV600E mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma

Fig. 3

Receiver operating characteristic (ROC) curves of (a) age < 55 years old (area under the ROC curve [AUROC] = 0.664), tumor size > 10 mm (AUROC = 0.612), microcalcification (AUROC = 0.626), non-concomitant Hashimoto’s thyroiditis (AUROC = 0.606) and BRAFV600E mutation (AUROC = 0.637), respectively. (b) Equation (AUROC = 0.845) for the prediction of cervical CLNM

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us